Insys Therapeutics, Inc. — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2018)

$82.1M

Net Income/Loss (FY2018)

-$124.5M

Total Assets (FY2018)

$192.5M

Total Equity (FY2018)

-$43.1M

Cash Flows from Operating Activities (FY2018)

-$56.0M

Source: Insys Therapeutics, Inc. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.